Christopher V. Lutman

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

Christopher V. Lutman, Laura J. Havrilesky, Janiel M. Cragun et al. · Gynecologic Oncology · 2006 · 205 citations

Tumoral Pathology, Endocrine-related Cancer, Ii Endometrial Carcinoma +10

Preoperative identification of patients at risk for delirium after major head and neck cancer surgery

Harrison G. Weed, Christopher V. Lutman, Donn C. Young et al. · The Laryngoscope · 1995 · 93 citations

Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: A Gynecologic Oncology Group Study

Allan Covens, Virginia L. Filiaci, Deborah J. Gersell et al. · Gynecologic Oncology · 2010 · 74 citations

Tumoral Pathology, Medicine, Phase Ii Study +6

Expression of a novel oncofetal mRNA-binding protein IMP3 in endometrial carcinomas: diagnostic significance and clinicopathologic correlations

Cuizhen Li, Victor Zota, Bruce A. Woda et al. · Modern Pathology · 2007 · 73 citations · Full text

Tumor Biology, Tumoral Pathology, Oncogenic Agent +9

Improving quality and decreasing cost in gynecologic oncology care. Society of gynecologic oncology recommendations for clinical practice

B.J. Rimel, William M. Burke, Robert V. Higgins et al. · Gynecologic Oncology · 2015 · 38 citations

Nursing, Healthcare Value, Gynecologic Oncology Recommendations +8